Global NSAIDs Market Growth 2025-2031

Publication ID:

LPI01254715

Publication Date:

January 14, 2025

Pages:

115

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global NSAIDs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淣SAIDs Industry Forecast鈥� looks at past sales and reviews total world NSAIDs sales in 2024, providing a comprehensive analysis by region and market sector of projected NSAIDs sales for 2025 through 2031. With NSAIDs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world NSAIDs industry.
This Insight Report provides a comprehensive analysis of the global NSAIDs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on NSAIDs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global NSAIDs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for NSAIDs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global NSAIDs.
This report presents a comprehensive overview, market shares, and growth opportunities of NSAIDs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others
Segmentation by Application:
Back Pain Treatment
Osteoarthritis Treatment
Other Disease Treatment
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bayer
Novacap
Abbott
Pfizer
Johnson & Johnson
Cigna
Geri-Care Pharmaceuticals
Perrigo Company
Kopran
Merck Sharp & Dohme
Sun Pharmaceutical Industries
GlaxoSmithKline
Reddy Pharmaceuticals
Verywell
Key Questions Addressed in this Report
What is the 10-year outlook for the global NSAIDs market?
What factors are driving NSAIDs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do NSAIDs market opportunities vary by end market size?
How does NSAIDs break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global NSAIDs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for NSAIDs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for NSAIDs by Country/Region, 2020, 2024 & 2031
2.2 NSAIDs Segment by Type
2.2.1 Aspirin
2.2.2 Ibuprofen
2.2.3 Naproxen
2.2.4 Nabumetone
2.2.5 Others
2.3 NSAIDs Sales by Type
2.3.1 Global NSAIDs Sales Market Share by Type (2020-2025)
2.3.2 Global NSAIDs Revenue and Market Share by Type (2020-2025)
2.3.3 Global NSAIDs Sale Price by Type (2020-2025)
2.4 NSAIDs Segment by Application
2.4.1 Back Pain Treatment
2.4.2 Osteoarthritis Treatment
2.4.3 Other Disease Treatment
2.5 NSAIDs Sales by Application
2.5.1 Global NSAIDs Sale Market Share by Application (2020-2025)
2.5.2 Global NSAIDs Revenue and Market Share by Application (2020-2025)
2.5.3 Global NSAIDs Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global NSAIDs Breakdown Data by Company
3.1.1 Global NSAIDs Annual Sales by Company (2020-2025)
3.1.2 Global NSAIDs Sales Market Share by Company (2020-2025)
3.2 Global NSAIDs Annual Revenue by Company (2020-2025)
3.2.1 Global NSAIDs Revenue by Company (2020-2025)
3.2.2 Global NSAIDs Revenue Market Share by Company (2020-2025)
3.3 Global NSAIDs Sale Price by Company
3.4 Key Manufacturers NSAIDs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers NSAIDs Product Location Distribution
3.4.2 Players NSAIDs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for NSAIDs by Geographic Region
4.1 World Historic NSAIDs Market Size by Geographic Region (2020-2025)
4.1.1 Global NSAIDs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global NSAIDs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic NSAIDs Market Size by Country/Region (2020-2025)
4.2.1 Global NSAIDs Annual Sales by Country/Region (2020-2025)
4.2.2 Global NSAIDs Annual Revenue by Country/Region (2020-2025)
4.3 Americas NSAIDs Sales Growth
4.4 APAC NSAIDs Sales Growth
4.5 Europe NSAIDs Sales Growth
4.6 Middle East & Africa NSAIDs Sales Growth
5 Americas
5.1 Americas NSAIDs Sales by Country
5.1.1 Americas NSAIDs Sales by Country (2020-2025)
5.1.2 Americas NSAIDs Revenue by Country (2020-2025)
5.2 Americas NSAIDs Sales by Type (2020-2025)
5.3 Americas NSAIDs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NSAIDs Sales by Region
6.1.1 APAC NSAIDs Sales by Region (2020-2025)
6.1.2 APAC NSAIDs Revenue by Region (2020-2025)
6.2 APAC NSAIDs Sales by Type (2020-2025)
6.3 APAC NSAIDs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe NSAIDs by Country
7.1.1 Europe NSAIDs Sales by Country (2020-2025)
7.1.2 Europe NSAIDs Revenue by Country (2020-2025)
7.2 Europe NSAIDs Sales by Type (2020-2025)
7.3 Europe NSAIDs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa NSAIDs by Country
8.1.1 Middle East & Africa NSAIDs Sales by Country (2020-2025)
8.1.2 Middle East & Africa NSAIDs Revenue by Country (2020-2025)
8.2 Middle East & Africa NSAIDs Sales by Type (2020-2025)
8.3 Middle East & Africa NSAIDs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of NSAIDs
10.3 Manufacturing Process Analysis of NSAIDs
10.4 Industry Chain Structure of NSAIDs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 NSAIDs Distributors
11.3 NSAIDs Customer
12 World Forecast Review for NSAIDs by Geographic Region
12.1 Global NSAIDs Market Size Forecast by Region
12.1.1 Global NSAIDs Forecast by Region (2026-2031)
12.1.2 Global NSAIDs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global NSAIDs Forecast by Type (2026-2031)
12.7 Global NSAIDs Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer NSAIDs Product Portfolios and Specifications
13.1.3 Bayer NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 Novacap
13.2.1 Novacap Company Information
13.2.2 Novacap NSAIDs Product Portfolios and Specifications
13.2.3 Novacap NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Novacap Main Business Overview
13.2.5 Novacap Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott NSAIDs Product Portfolios and Specifications
13.3.3 Abbott NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer NSAIDs Product Portfolios and Specifications
13.4.3 Pfizer NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson NSAIDs Product Portfolios and Specifications
13.5.3 Johnson & Johnson NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Cigna
13.6.1 Cigna Company Information
13.6.2 Cigna NSAIDs Product Portfolios and Specifications
13.6.3 Cigna NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Cigna Main Business Overview
13.6.5 Cigna Latest Developments
13.7 Geri-Care Pharmaceuticals
13.7.1 Geri-Care Pharmaceuticals Company Information
13.7.2 Geri-Care Pharmaceuticals NSAIDs Product Portfolios and Specifications
13.7.3 Geri-Care Pharmaceuticals NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Geri-Care Pharmaceuticals Main Business Overview
13.7.5 Geri-Care Pharmaceuticals Latest Developments
13.8 Perrigo Company
13.8.1 Perrigo Company Company Information
13.8.2 Perrigo Company NSAIDs Product Portfolios and Specifications
13.8.3 Perrigo Company NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Perrigo Company Main Business Overview
13.8.5 Perrigo Company Latest Developments
13.9 Kopran
13.9.1 Kopran Company Information
13.9.2 Kopran NSAIDs Product Portfolios and Specifications
13.9.3 Kopran NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Kopran Main Business Overview
13.9.5 Kopran Latest Developments
13.10 Merck Sharp & Dohme
13.10.1 Merck Sharp & Dohme Company Information
13.10.2 Merck Sharp & Dohme NSAIDs Product Portfolios and Specifications
13.10.3 Merck Sharp & Dohme NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Merck Sharp & Dohme Main Business Overview
13.10.5 Merck Sharp & Dohme Latest Developments
13.11 Sun Pharmaceutical Industries
13.11.1 Sun Pharmaceutical Industries Company Information
13.11.2 Sun Pharmaceutical Industries NSAIDs Product Portfolios and Specifications
13.11.3 Sun Pharmaceutical Industries NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Sun Pharmaceutical Industries Main Business Overview
13.11.5 Sun Pharmaceutical Industries Latest Developments
13.12 GlaxoSmithKline
13.12.1 GlaxoSmithKline Company Information
13.12.2 GlaxoSmithKline NSAIDs Product Portfolios and Specifications
13.12.3 GlaxoSmithKline NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 GlaxoSmithKline Main Business Overview
13.12.5 GlaxoSmithKline Latest Developments
13.13 Reddy Pharmaceuticals
13.13.1 Reddy Pharmaceuticals Company Information
13.13.2 Reddy Pharmaceuticals NSAIDs Product Portfolios and Specifications
13.13.3 Reddy Pharmaceuticals NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Reddy Pharmaceuticals Main Business Overview
13.13.5 Reddy Pharmaceuticals Latest Developments
13.14 Verywell
13.14.1 Verywell Company Information
13.14.2 Verywell NSAIDs Product Portfolios and Specifications
13.14.3 Verywell NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Verywell Main Business Overview
13.14.5 Verywell Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂